Antigen-Based Rapid Diagnostic Tests
Commercial sector
Antigen-Based Rapid Diagnostic Tests
Companies developing or manufacturing lateral-flow immunochromatographic rapid diagnostic tests for malaria that detect parasite antigens (HRP2, pLDH, aldolase) using colloidal gold or similar visual readout technologies, designed for instrument-free point-of-care use.
Companies62
Commercial products186
Technology classes2
Countries19
Patents147
Profiled companies
Products
- Biopanda ReagentsUnited Kingdom4
- CellabsAustralia–
- CellexUnited States5
- Healgen Scientific LLCUnited States2
- HumasisSouth Korea5
- Incas Diagnostics LimitedGhana2
+ 56 more